A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes
Clinical trial NCT05353686 · COMPLETED
Trial details
- NCT number
- NCT05353686
- Sponsor
- Pila Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-25
- Primary completion
- 2019-12-19
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.